United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 5, 2026

On Jun 4, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$546.33 for US$5.19M under a trading plan, leaving 40,513 shares. Filed Jun 5, 2026 (Form 4).

Sold
9,500 shares
Price
US$546.33 average (US$539.51 to US$550.46)
Value
US$5.19M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 4, 2026Common StockSale120US$539.5149,893Direct
Jun 4, 2026Common StockSale473US$541.0849,420Direct
Jun 4, 2026Common StockSale112US$542.5049,308Direct
Jun 4, 2026Common StockSale396US$543.1148,912Direct
Jun 4, 2026Common StockSale1,470US$544.2447,442Direct
Jun 4, 2026Common StockSale1,186US$545.1846,256Direct
Jun 4, 2026Common StockSale1,202US$546.1445,054Direct
Jun 4, 2026Common StockSale1,525US$547.5343,529Direct
Jun 4, 2026Common StockSale1,676US$548.2641,853Direct
Jun 4, 2026Common StockSale780US$549.2441,073Direct
Jun 4, 2026Common StockSale560US$550.4640,513Direct

Source

View original at SEC

Related